Replies to post #2135 on Biomoda Inc. (fka BMODQ)

[The Rainmaker]

I always was curious what the record was for using the same word over and over the most times in one post. Your bungle post has to be in the running.

[The Rainmaker]

This part of your post was wrong as well....

We still don't really know why the study was bungled,

We were told exactly what happened and what needed to be done. Some of the 21 samples from the second cohort need to be replaced because the cancer from those samples started in other parts of the body and spread to the lungs. Here was a portion of the PR that clearly explained this.

We thought we had secured sufficient samples, but further investigation showed that some of these lung cancer patients do not fit the FDA-approved criteria for inclusion in the positive control group. Some of the patients’ cancer is located outside the lung cavity. Under the protocol submitted to the FDA, these patients must be excluded from the study,” Cousins said

[The Rainmaker]

Impossible for any to know this part for sure....I can think of 15 ways this will not be possible. Partnering with larger player is one right off the top of my head. Second more accurate would be how long will shares around the .11 range be around. I don't think for very much longer. Buying at .11 when this gets to .20 that person would already be up over 80%. Big difference between paying .11 per share and .20 per share.

IMO you'll have every chance to buy as many shares as you want under .20 within the next 9 months to a year.